Enrichment of infant formula with omega-3 fatty acids

Food Enrichment with Omega-3 Fatty Acids

Volumn , Issue , 2013, Pages 353-386

  Kuratko, C ^a   Abril, J R ^a   Hoffman, J P ^a   Salem, N ^a  

^a DSM NUTRITIONAL PRODUCTS   (United States)

Author keywords

Arachidonic acid; Docosahexaenoic acid; Infant formula; Neurocognitive development; Omega 3 fatty acids; Visual development

Indexed keywords

EID: 84922598969     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9780857098863.3.353     Document Type: Chapter

References (161)

1. Aap Committee on Nutrition Pediatric Nutrition Handbook 2009, American Academics of Pediatrics, Elk Grove Village, IL. 6th edn.
2. Abril J., Wills T. 2009, Unpublished data.
3. Agostoni C., Trojan S., Bellu R., Riva E., Giovannini M. Neurodevelop-mental quotient of healthy term infants at 4 months and feeding practice: the role of long-chain polyunsaturated fatty acids. Pediatr Res 1995, 38:262-266.
4. Agostoni C., Trojan S., Bellu R., Riva E., Bruzzese M.G., Giovannini M. Developmental quotient at 24 months and fatty acid composition of diet in early infancy: a follow up study. Arch Dis Child 1997, 76:421-424.
5. Ahmad A., Moriguchi T., Salem N. Decrease in neuron size in docosahexaenoic acid-deficient brain. Pediatr Neurol 2002, 26:210-218.
6. Akbar M., Calderon F., Zhiming W., Kim H. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci USA 2005, 102:10858-10863.
7. Anupama K., Ravi R., Rajalakshim D. Sensory profiling and positioning of commercial samples of milk powder. J Sens Stud 1999, 14:303-319.
8. Aruoma O.I. Free radicals, oxidative stress, and antioxidants in human health and disease. J Am Oil Chem Soc 1998, 75:199-212.
9. Bazan N.G., Molina M.F., Gordon W.C. Docosahexaenoic acid signalo-lipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu Rev Nutr 2011, 31:321-351.
10. Birch E.E., Birch D.G., Hoffman D.R., Uauy R. Dietary essential fatty acid supply and visual acuity development. Invest Ophthalmol Vis Sci 1992, 33:3242-3253.
11. Birch E., Birch D., Hoffman D., Hale L., Everett M., Uauy R. Breastfeeding and optimal visual development. J Pediatr Ophthalmol Strabismus 1993, 30:33-38.
12. Birch E.E., Hoffman D.R., Uauy R., Birch D.G., Prestidge C. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res 1998, 44:201-209.
13. Birch E.E., Garfield S., Hoffman D.R., Uauy R., Birch D.G. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol 2000, 42:174-181.
14. Birch E.E., Hoffman D.R., Castañeda Y.S., Fawcett S.L., Birch D.G., Uauy R.D. A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age. Am J Clin Nutr 2002, 75:570-580.
15. Birch E.E., Castañeda Y.S., Wheaton D.H., Birch D.G., Uauy R.D., Hoffman D.R. Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mo. Am J Clin Nutr 2005, 81:871-879.
16. Birch E.E., Garfield S., Castañeda Y., Hughbanks-Wheaton D., Uauy R., Hoffman D. Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early Hum Dev 2007, 83:279-284.
17. Birch E.E., Carlson S.E., Hoffman D.R., Fitzgerald-Gustafson K.M., Fu V.L., Drover J.R., Castañeda Y.S., Minns L., Wheaton D.K., Mundy D., Marunycz J., Diersen-Schade D.A. The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am J Clin Nutr 2010, 91:848-859.
18. Bodyfelt F., Tobias W., Trout G. The Sensory Evaluation of Dairy Products 1998, AVI, Westport, CT.
19. Bougle D., Denise P., Vimard F., Nouvelot A., Penneillo M.J., Guillois B. Early neurological and neuropsychological development of the preterm infant and polyunsaturated fatty acids supply. Clin Neurophysiol 1999, 110:1363-1370.
20. Breckenridge W.C., Gombos G., Morgan I.G. The lipid composition of adult rat brain synaptosomal plasma membranes. Biochim Biophys Acta 1972, 266:695-707.
21. Brenna J.T., Varamini B., Jensen R.G., Diersen-Schade D.A., Boettcher J.A., Arterburn L.M. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am J Clin Nutr 2007, 85:1457-1464.
22. Calderon F., Kim H.Y. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J Neurochem 2004, 90:979-988.
23. Carlson S.E., Werkman S.H. A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until two months. Lipids 1996, 31:85-90.
24. Carlson S.E., Cooke R.J., Werkman S.H., Tolley E.A. First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula. Lipids 1992, 27:901-907.
25. Carlson S.E., Werkman S.H., Peeples J.M., Cooke R.J., Tolley E.A. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci USA 1993, 90:1073-1077.
26. Carlson S.E., Werkman S.H., Rhodes P.G., Tolley E.A. Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation. Am J Clin Nutr 1993, 58:35-42.
27. Carlson S.E., Ford A.J., Werkman S.H., Peeples J.M., Koo W.W. Visual acuity and fatty acid status of term infants fed human milk and formulas with and without docosahexaenoate and arachidonate from egg yolk lecithin. Pediatr Res 1996, 39:882-888.
28. Carlson S.E., Werkman S.H., Tolley E.A. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. Am J Clin Nutr 1996, 63:687-697.
29. Castilho S.D., Barros Filho A.A. The history of infant nutrition. J Pediatr (Rio J) 2010, 86:179-188.
30. Clandinin M.T.V. Growth and development of very-low-birth-weight infants (VLBW) is enhanced by formulas supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA). J Pediatr Gastroenterol Nutr 2002, 34:479-485.
31. Clandinin M.T., Chappell J.E., Leong S., Heim T., Swyer P.R., Chance G.W. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 1980, 4:121-129.
32. Clandinin M.T., Chappell J.E., Leong S., Heim T., Swyer P.R., Chance G.W. Extrauterine fatty acid accretion in infant brain: implications for fatty acid requirements. Early Hum Dev 1980, 4:131-138.
33. Clandinin M.T., Van Aerde J.E., Parrott A., Held C.J., Euler A.R., Lien E.L. Assessment of the efficacious dose of arachidonic and docosahexaenoic acids in preterm infant formulas: fatty acid composition of erythrocyte membrane lipids. Pediatr Res 1997, 42:819-825.
34. Clandinin M.T., Van Aerde J.E., Merkel K.L., Harris C.L., Springer M.A., Hansen J.W., Diersen-Schade D.A. Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. J Pediatr 2005, 146:461-468.
35. Clark S., Costello M., Drake M., Bodyfelt F. Sensory Evaluation of Dairy Products 2009, Springer, New York. 2nd edn.
36. Codex Alimentarius Commission Standard for infant formula and formulas for special medical purposes intended for infants 2007, CODEX STAN 72-1981, revised 2007, available at:, [accessed February 2013]. http://www.codexalimentarius.net/download/standards/288/CXS_072e.pdf.
37. Colombo J., Carlson S.E., Cheatham C., Fitzgerald-Gustafson K., Kepler A., Doty T. Long-chain polyunsaturated fatty acid supplementation in infancy reduces heart rate and positively affects distribution of attention. Pediatr Res 2011, 70:406-410.
38. Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and amending Directive 1999/21/EC. OJ, L401/1401/33.
39. Crawford M.A. The role of essential fatty acids in neural development: implications for perinatal nutrition. Am J Clin Nutr 1993, 57:703S-709S. discussion 709S-710S.
40. Cunnane S.C. Problems with essential fatty acids: time for a new paradigm?. Prog Lipid Res 2003, 42:544-568.
41. Cunnane S.C., Francescutti V., Brenna J.T., Crawford M.A. Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formula-fed infants not consuming dietary docosahexaenoate. Lipids 2000, 35:105-111.
42. Demmelmair H., Von Rosen J., Koletzko B. Long-term consequences of early nutrition. Early Hum Dev 2006, 82:567-574.
43. Dobbing J., Sands J. Quantitative growth and development of human brain. Arch Dis Child 1973, 48:757-767.
44. Drake M.A., Karagul-Yuceer Y., Cadwallader K.R., Civille C.V., Tong P.S. Determination of the sensory attributes of dried milk powders and dairy ingredients. J Sens Stud 2003, 18:199-216.
45. Drover J., Hoffman D.R., Castañeda Y.S., Morale S.E., Birch E.E. Three randomized controlled trials of early long-chain polyunsaturated fatty acid supplementation on means-end problem solving in 9-month-olds. Child Dev 2009, 80(5):1376-1384.
46. Drover J.R., Hoffman D.R., Castañeda Y.S., Morale S.E., Garfield S., Wheaton D.H., Birch E.E. Cognitive function in 18-month-old term infants of the DIAMOND study: a randomized, controlled clinical trial with multiple dietary levels of docosahexaenoic acid. Early Hum Dev 2011, 87:223-230.
47. Eldho N., Feller S., Tristram-Nagle S., Polozov I., Gawrisch K. Polyunsaturated docosahexaenoic vs docosapentaenoic acid - differences in lipid matrix properties from the loss of one double bond. J Am Chem Soc 2003, 125:6409-6421.
48. Eunok C., David B.M. Mechanisms of antioxidants in the oxidation of foods. Comp Rev in Food Sci Food Safety 2009, 8:345-358.
49. Faldella G., Govoni M., Alessandroni R., Marchiani E., Salvioli G.P., Biagi P.L., Spano C. Visual evoked potentials and dietary long chain polyunsaturated fatty acids in preterm infants. Arch Dis Child Fetal Neonatal Ed 1996, 75:F108-F112.
50. Fao/Who Fats and fatty acids in human nutrition: report of an expert consultation 2010, FAO Food and Nutrition Paper 91, Rome: Food and Agriculture Organization of the United Nations.
51. Farquharson J., Cockburn F., Patrick W.A., Jamieson E.C., Logan R.W. Infant cerebral cortex phospholipid fatty-acid composition and diet. Lancet 1992, 340:810-813.
52. Farquharson J., Jamieson E.C., Abbasi K.A., Patrick W.J., Logan R.W., Cockburn F. Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex. Arch Dis Child 1995, 72:198-203.
53. Feller S., Gawrisch K., Mackerell A. Polyunsaturated fatty acids in lipid bilayers: intrinsic and environmental contributions to their unique physical properties. J Am Chem Soc 2002, 124:318-326.
54. Fewtrell M.S., Morley R., Abbott R.A., Singhal A., Isaacs E.B., Stephenson T., Macfadyen U., Lucas A. Double-blind, randomized trial of long-chain polyunsaturated fatty acid supplementation in formula fed to preterm infants. Pediatrics 2002, 110:73-82.
55. Fewtrell M.S., Abbott R.A., Kennedy K., Singhal A., Morley R., Caine E., Jamieson C., Cockburn F., Lucas A. Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. J Pediatr 2004, 144:471-479.
56. Fleith M., Clandinin M.T. Dietary PUFA for preterm and term infants: review of clinical studies. Crit Rev Food Sci Nutr 2005, 45:205-229.
57. Fomon S. Infant feeding in the 20th century: formula and beikost. J Nutr 2001, 131:409S-420S.
58. Francois C.A., Connor S.L., Bolewicz L.C., Connor W.E. Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk. Am J Clin Nutr 2003, 77:226-233.
59. Fsanz Australia New Zealand Food Standards Code - Amendment 2007, No. 95, Gazette No. FSC 37, 13 December, available at:, Canberra: Food Standards Australia New Zealand, [accessed February 2013]. http://www.foodstandards.gov.au/_srcfiles/Gazette_Notice_Amendment_No_95.pdf.
60. Galdi M., Carbone N., Valencia M.E. Comparison of ferric glycinate to ferrous sulfate in model infant formulas: kinetics of vitamin losses. J of Food Sci 1989, 54:1530-1539.
61. Galli C., Trzeciak H.I., Paoletti R. Effects of dietary fatty acids on the fatty acid composition of brain ethanolamine phosphoglyceride: Reciprocal replacement on n-6 and n-3 polyunsaturated fatty acids. Biochim Biophys Acta Neurol Scand 1971, 248:449-454.
62. Garcia-Llatas G., Lagarda M.J., Clemente G., Farre R. Monitoring of headspace volatiles in milk-cereal-based liquid infant foods during storage. Eur J Lipid Sci 2006, 108:1028-1036.
63. Gawrisch K., Soubia O. Structure and dynamics of polyunsaturated hydrocarbon chains in lipid bilayers-significance for GPCR function. Chem Phys Lipids 2008, 153:64-75.
64. German J.B. Dietary lipids from an evolutionary perspective: sources, structures and functions. Matern Child Nutr 2011, 7(Suppl 2):2-16.
65. Gibson R.A., Neumann M.A., Makrides M. Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants. Eur J Clin Nutr 1997, 51:578-584.
66. Gil-Sanchez A., Koletzko B., Larqué E. Current understanding of placental fatty acid transport. Curr Opin Clin Nutr Metab Care 2012, 15:265-272.
67. Greiner R.S., Catalan J.N., Moriguchi T., Salem N. Docosapentaenoic acid does not completely replace DHA in n-3 FA-deficient rats during early development. Lipids 2003, 38:431-435.
68. Hadley K.B., Ryan A.S., Nelson E.B., Salem N. An assessment of dietary docosahexaenoic acid requirements for brain accretion and turnover during early childhood. World Rev Nutr Diet 2009, 99:97-104.
69. Harbige L.S. Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 2003, 38:323-341.
70. Heird W.C., Lapillonne A. The role of essential fatty acids in development. Annu Rev Nutr 2005, 25:549-571.
71. Helland I.B., Smith L., Saarem K., Saugstad O.D., Drevon C.A. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003, 111:e39-e44.
72. Helland I.B., Smith L., Blomen B., Saarem K., Saugstad O.D., Drevon C.A. Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children's IQ and body mass index at 7 years of age. Pediatrics 2008, 122:e472-e479.
73. Henriksen C., Haugholt K., Lindgren M., Aurvag A.K., Ronnestad A., Gronn M., Solberg R., Moen A., Nakstad B., Berge R.K., Smith L., Iversen P.O., Drevon C.A. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachi-donic acid. Pediatrics 2008, 121:1137-1145.
74. Hodge C.W., Barnes D., Schachter H., Pan Y., Lowcock E., Zhang L., Sampson M., Morrison A., Tran K., Miguelez M., Lewin G. Effects of omega-3 fatty acids on eye health 2005, Evidence Report/Technology Assessment No. 117, AHRQ Publication No. 05-E008-2. Rockeville, MN: Agency for Healthcare Research and Quality.
75. Hoffman D.R. LCPUFA levels for breastfeeding and weaning infants: visual acuity outcomes. Pediatr Perspect 2003, 2:1.
76. Hoffman D.R., Birch E.E., Birch D.G., Uauy R.D. Effects of supplementation with omega 3 long-chain polyunsaturated fatty acids on retinal and cortical development in premature infants. Am J Clin Nutr 1993, 57:807S-812S.
77. Hoffman D.R., Birch E.E., Castañeda Y.S., Fawcett S.L., Wheaton D.H., Birch D.G., Uauy R. Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: a randomized clinical trial. J Pediatr 2003, 142:669-677.
78. Hoffman D.R., Boettcher J.A., Diersen-Schade D.A. Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials. Prostaglandins Leukot Essent Fatty Acids 2009, 81:151-158.
79. Innis S.M. Essential fatty acids in growth and development. Prog Lipid Res 1991, 30:39-103.
80. Innis S.M. Human milk and formula fatty acids. J Pediatr 1992, 120:S56-S61.
81. Innis S.M., Gilley J., Werker J. Are human milk long-chain polyunsaturated fatty acids related to visual and neural development in breast-fed term infants?. J Pediatr 2001, 139:532-538.
82. Innis S.M., Foote K.D., Mackinnon M.J., King D.J. Plasma and red blood cell fatty acids of low-birth-weight infants fed their mother's expressed breast milk or preterm-infant formula. Am J Clin Nutr 1990, 51:994-1000.
83. Innis S.M., Adamkin D.H., Hall R.T., Kalhan S.C., Lair C., Lim M., Stevens D.C., Twist P.F., Diersen-Schade D.A., Harris C.L., Merkel K.L., Hansen J.W. Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula. J Pediatr 2002, 140:547-554.
84. Innis S.M., Davidson A.G., Chen A., Dyer R., Melnyk S., James S.J. Increased plasma homocysteine and S-adenosylhomocysteine and decreased methionine is associated with altered phosphatidylcholine and phosphatidyl-ethanolamine in cystic fibrosis. J Pediatr 2003, 143:351-356.
85. Jacobsen C. Omega-3's in food emulsions: overview and case studies. Agro Food Ind Hi-Tech 2008, 19:9-12.
86. Jensen C.L., Lapillonne A. Docosahexaenoic acid and lactation. Prostaglandins Leukot Essent Fatty Acids 2009, 81:175-178.
87. Jensen C.L., Voigt R.G., Prager T.C., Zou Y.L., Fraley J.K., Rozelle J.C., Turcich M.R., Llórente A.M., Anderson R.E., Heird W.C. Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. Am J Clin Nutr 2005, 82:125-132.
88. Jensen C.L., Voigt R.G., Llórente A.M., Peters S.U., Prager T.C., Zou Y.L., Rozelle J.C., Turcich M.R., Fraley J.K., Anderson R.E., Heird W.C. Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants. J Pediatr 2010, 157:900-905.
89. Jorgensen M.H., Hernell O., Hughes E., Michaelsen K.F. Is there a relation between docosahexaenoic acid concentration in mothers' milk and visual development in term infants?. J Pediatr Gastroenterol Nutr 2001, 32:293-296.
90. Kamal-Eldin A., Yanishlieva N.V. N-3 fatty acids for human nutrition: Stability considerations. Eur J Lipid Sci Technol 2002, 104:825-836.
91. Kohn G., Sawatzki G., Van Biervliet J.P., Rosseneu M. Diet and the essential fatty acid status of term infants. Acta Paediatr Suppl 1994, 402:69-74.
92. Koletzko B., Braun M. Arachidonic acid and early human growth: is there a relation?. Ann Nutr Metab 1991, 35:128-131.
93. Koletzko B., Schmidt E., Bremer H.J., Haug M., Harzer G. Effects of dietary long-chain polyunsaturated fatty acids on the essential fatty acid status of premature infants. Eur J Pediatr 1989, 148:669-675.
94. Koletzko B., Thiel I., Abiodun P.O. The fatty acid composition of human milk in Europe and Africa. J Pediatr 1992, 120:S62-S70.
95. Koletzko B., Edenhofer S., Lipowsky G., Reinhardt D. Effects of a low birthweight infant formula containing human milk levels of docosahexaenoic and arachidonic acids. J Pediatr Gastroenterol Nutr 1995, 21:200-208.
96. Koletzko B., Baker S., Cleghorn G., Neto U.F., Gopalan S., Hernell O., Hock Q.S., Jirapinyo P., Lonnerdal B., Pencharz P., Pzyrembel H., Ramirez-Mayans J., Shamir R., Turck D., Yamashiro Y., Song-Yi D. Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. J Pediatr Gastroent Nutr 2005, 41:584-599.
97. Koletzko B., Lien E., Agostoni C., Bohles H., Campoy C., Cetin I., Decsi T., Dudenhausen J.W., Dupont C., Forsyth S., Hoesli I., Holzgreve W., Lapillonne A., Putet G., Secher N.J., Symonds M., Szajewska H., Willatts P., Uauy R. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 2008, 36:5-14.
98. Kremmyda L.S., Tvrzicka E., Stankova B., Zak A. Fatty acids as biocom-pounds: their role in human metabolism, health and disease: a review. Part 2: fatty acid physiological roles and applications in human health and disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011, 155(3):195-218.
99. Kris-Etherton P.M., Innis S., American Dietetic Association and Dietitians Of Canada Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J Am Diet Assoc 2007, 107:1599-1611.
100. Kuratko C.N., Hoffman J.P., Van Elswyk M.E., Salem N. Recent developments in the human nutrition of polyunsaturated fatty acids from single cell oils. Single Cell Oils, Microbial and Algal Oils 2010, 369-387. AOCS Press, Chicago IL. 2nd edn. Z. Cohen, C. Ratledge (Eds.).
101. Lands W.E. Biochemistry and physiology of n-3 fatty acids. FASEB J 1992, 6:2530-2536.
102. Lauritzen L., Jorgensen M.H., Mikkelsen T.B., Skovgaard M., Straarup E.M., Olsen S.F., Hoy C.E., Michaelsen K.F. Maternal fish oil supplementation in lactation: effect on visual acuity and n-3 fatty acid content of infant erythrocytes. Lipids 2004, 39:195-206.
103. Lauritzen L., Jorgensen M.H., Olsen S.F., Straarup E.M., Michaelsen K.F. Maternal fish oil supplementation in lactation: effect on developmental outcome in breast-fed infants. Reprod Nutr Dev 2005, 45:535-547.
104. Lewin G.A., Schachter H.M., Yuen D., Merchant P., Mamaladze V., Tsertsvadze A. Effects of omega-3 fatty acids on child and maternal health. Evid Rep Technol Assess (Summ) 2005, 1-11.
105. Liclican E.L., Gronert K. Molecular circuits of resolution in the eye. Scientific World Journal 2010, 10:1029-1047.
106. Lien E.L., Hammond B.R. Nutritional influences on visual development and function. Prog Retin Eye Res 2011, 30:188-203.
107. Life Sciences Research Office American Societies for Nutritional Sciences. Assessments of nutritional requirements for infant formulas. J Nutr 1988, 128:2059S-2298S.
108. Lim S.Y., Hoshiba J., Salem N. An extraordinary degree of structural specificity is required in neural phospholipids for optimal brain function: n-6 docosapentaenoic acid substitution for docosahexaenoic acid leads to a loss in spatial task performance. J Neurochem 2005, 95:848-857.
109. Makrides M., Neumann M.A., Byard R.W., Simmer K., Gibson R.A. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr 1994, 60:189-194.
110. Makrides M., Neumann M., Simmer K., Pater J., Gibson R. Are long-chain polyunsaturated fatty acids essential nutrients in infancy?. Lancet 1995, 345:1463-1468.
111. Makrides M., Neumann M.A., Gibson R.A. Effect of maternal docosa-hexaenoic acid (DHA) supplementation on breast milk composition. Eur J Clin Nutr 1996, 50:352-357.
112. Makrides M., Gibson R.A., Udell T., Ried K. Supplementation of infant formula with long-chain polyunsaturated fatty acids does not influence the growth of term infants. Am J Clin Nutr 2005, 81:1094-1101.
113. Makrides M., Gibson R.A., Mcphee A.J., Collins C.T., Davis P.G., Doyle L.W., Simmer K., Colditz P.B., Morris S., Smithers L.G., Willson K., Ryan P. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA 2009, 301:175-182.
114. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992, 120:S129-S138.
115. Martinez M., Mougan I. Fatty acid composition of human brain phospholipids during normal development. J Neurochem 1998, 71:2528-2533.
116. Mcclements D.J. Emulsion design to improve the delivery of functional lipophilic components. Annu Rev Food Sci Technol 2010, 1:241-269.
117. Meilgaard M., Civille G.V., Carr B.T. Sensory Evaluation Techniques 1999, CRC Press, Boca Raton, FL, London, New York, Washington, DC. 3rd edn.
118. Meldrum S.J., D'vaz N., Simmer K., Dunstan J.A., Hird K., Prescott S.L. Effects of high-dose fish oil supplementation during early infancy on neurodevelopment and language: a randomised controlled trial. Br J Nutr 2012, 108:1443-1454.
119. Morale S.E., Hoffman D.R., Castañeda Y.S., Wheaton D.H., Burns R.A., Birch E.E. Duration of long-chain polyunsaturated fatty acids availability in the diet and visual acuity. Early Hum Dev 2005, 81:197-203.
120. Moriguchi T., Salem N. Recovery of brain docosahexaenoate leads to recovery of spatial task performance. J Neurochem 2003, 87:297-309.
121. Moriguchi T., Loewke J., Garrison M., Catalan J.N., Salem N. Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum. J Lipid Res 2001, 42:419-427.
122. Murphy C.L., Cardello A.V., Brand J.G. Taste of fifteen halide salts following water and NaCl: Anion and cation effects. Physiol Behav 1981, 26:1083-1095.
123. Niu S.L., Mitchell D.C., Lim S.Y., Wen Z.M., Kim H.Y., Salem N., Litman B.J. Reduced G protein-coupled signaling efficiency in retinal rod outer segments in response to n-3 fatty acid deficiency. J Biol Chem 2004, 279:31098-31104.
124. O'brien J.S., Sampson E.L. Fatty acid and fatty aldehyde composition of the major brain lipids in normal human gray matter, white matter, and myelin. J Lipid Res 1965, 6:545-551.
125. O'connor D.L., Hall R., Adamkin D., Auestad N., Castillo M., Connor W.E., Connor S.L., Fitzgerald K., Groh-Wargo S., Hartmann E.E., Jacobs J., Janowsky J., Lucas A., Margeson D., Mena P., Neuringer M., Nesin M., Singer L., Stephenson T., Szabo J., Zemon V. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics 2001, 108:359-371.
126. Pivik R.T., Dykman R.A., Jing H., Gilchrist J.M., Badger T.M. Early infant diet and the omega 3 fatty acid DHA: effects on resting cardiovascular activity and behavioral development during the first half-year of life. Dev Neuropsychol 2009, 34:139-158.
127. Plagemann A., Davidowa H., Harder T., Dudenhausen J.W. Developmental programming of the hypothalamus: a matter of insulin. A comment on: Horvath, T. L., Bruning, J. C.: Developmental programming of the hypothalamus: a matter of fat. Nat Med 2006, 12:52-53.
128. Querques G., Avellis F.O., Querques L., Bandello F., Souied E.H. Age-related macular degeneration. Clin Ophthalmol 2011, 5:593-601.
129. Ries D. Studies on the antioxidant activity of milk proteins in model oil-in-water emulsions 2009, PhD thesis, Massey University, New Zealand.
130. Ross C. Physiology of sensory perception. Physiology of sensory perception 2009, 17-42. Springer, New York. 2nd edn. S. Clark, M. Costello, M. Drake, F. Bodyfelt (Eds.).
131. Ryan A.S., Montalto M.B., Groh-Wargo S., Mimouni F., Sentipal-Walerius J., Doyle J., Siegman J.S., Thomas A.J. Effect of DHA-containing formula on growth of preterm infants to 59 weeks postmenstrual age. Am J Hum Biol 1999, 11:457-467.
132. Salem N., Serpentino P., Puskin J., Abood L. Preparation and spectro-scopic characterization of molecular species of brain phosphatidylserines. Chem Phys Lipids 1980, 27:289-304.
133. Salem N., Hullin F., Yoffe A.M., Karanian J.W., Kim H.Y. Fatty acid and phospholipid species composition of rat tissues after a fish oil diet. Adv Prostaglandin Thromboxane Leukot Res 1989, 19:618-622.
134. Salem N., Wegher B., Mena P., Uauy R. Arachidonic and docosahexa-enoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc Natl Acad Sci U S A 1996, 93:49-54.
135. Sang N., Chen C. Lipid signaling and synaptic plasticity. Neuroscientist 2006, 12:425-434.
136. Sangiovanni J.P., Berkey C.S., Dwyer J.T., Colditz G.A. Dietary essential fatty acids, long-chain polyunsaturated fatty acids, and visual resolution acuity in healthy fullterm infants: a systematic review. Early Hum Dev 2000, 57:165-188.
137. Sangiovanni J.P., Parra-Cabrera S., Colditz G.A., Berkey C.S., Dwyer J.T. Meta-analysis of dietary essential fatty acids and long-chain polyunsatu-rated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics 2000, 105:1292-1298.
138. Schaich K. Lipid oxidation theoretical aspects. Baileys' Industrial Oil and Fat Products (6th edn) 2005, 269-355. Hoboken, NJ. F. Shahidi (Ed.).
139. Simmer K., Patole S.K., Rao S.C. Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2011, CD000376.
140. Singhal A., Lucas A. Early origins of cardiovascular disease: is there a unifying hypothesis?. Lancet 2004, 363:1642-1645.
141. Singhal A., Kattenhorn M., Cole T.J., Deanfield J., Lucas A. Preterm birth, vascular function, and risk factors for atherosclerosis. Lancet 2001, 358:1159-1160.
142. Smithers L.G., Gibson R.A., Mcphee A., Makrides M. Higher dose of docosahexaenoic acid in the neonatal period improves visual acuity of preterm infants: results of a randomized controlled trial. Am J Clin Nutr 2008, 88:1049-1056.
143. Smithers L.G., Gibson R.A., Mcphee A., Makrides M. Effect of long-chain polyunsaturated fatty acid supplementation of preterm infants on disease risk and neurodevelopment: a systematic review of randomized controlled trials. Am J Clin Nutr 2008, 87:912-920.
144. Smithers L.G., Collins C.T., Simmonds L.A., Gibson R.A., Mcphee A., Makrides M. Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trial. Am J Clin Nutr 2010, 91:628-634.
145. Stevens E.E., Patrick T.E., Pickler R. A history of infant feeding. J Perinat Educ 2009, 18:32-39.
146. Stillwell W., Shaikh S.R., Zerouga M., Siddiqui R., Wassall S.R. Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod Nutr Dev 2005, 45:559-579.
147. Svennerholm L. Distribution and fatty acid composition of phosphoglycer-ides in normal human brain. J Lipid Res 1968, 9:570-579.
148. Swanson D., Block R., Mousa S.A. Omega-3 fatty acids EPA and DHA: health benefits throughout life. Adv Nutr 2012, 3(1):1-7.
149. Taneja A., Zhu X. The trouble with omega-3 oils, Funct Ingred 2006, Sept 16-18.
150. Teagasc Food Research Center Workshop: Nutrient stability during infant formula manufacture and storage 2011, September 21-22.
151. Uauy R.D., Birch D.G., Birch E.E., Tyson J.E., Hoffman D.R. Effect of dietary omega-3 fatty acids on retinal function of very-low-birth-weight neonates. Pediatr Res 1990, 28:485-492.
152. Uauy R., Hoffman D.R., Mena P., Llanos A., Birch E.E. Term infant studies of DHA and ARA supplementation on neurodevelopment: results of randomized controlled trials. J Pediatr 2003, 143:S17-S25.
153. Us F.D.A. Rules and regulations: Label statements concerning dietary properties of food purporting to be or represented for specific dietary uses. Federal Register 1971, 36:23553-23556.
154. Us F.D.A. The Infant Formula Act of 1980 1980, Public Law No. 96-359, 94 Stat. 1190 [codified at 21 U.S.C.§350(a), 301, 321 (aa), 331, 374(a)]. September 26, 1980.
155. Us F.D.A. Agency Response Letter GRAS 2001, Notice No. GRN 000041, available at:, [accessed January 2013]. http://www.fda.gov/Food/FoodIngredientsPackaging/GenerallyRecognizedasSafeGRAS/GRASListings/ucm154126.htm.
156. Van Wezel-Meijler G., Van Der Knaap M.S., Huisman J., Jonkman E.J., Valk J., Lafeber H.N. Dietary supplementation of long-chain polyunsaturated fatty acids in preterm infants: effects on cerebral maturation. Acta Paediatr 2002, 91:942-950.
157. Werkman S.H., Carlson S.E. A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until nine months. Lipids 1996, 31:91-97.
158. Who Thirty-ninth world health assembly. Guidelines concerning the main health and socioeconomic circumstances in which infants have to be fed on breast-milk substitutes 1986, Geneva: World Health Organization, Ed A39/8 Add. 1: 1986.
159. Willatts P., Forsyth J.S., Dimodugno M.K., Varma S., Colvin M. Influence of long-chain polyunsaturated fatty acids on infant cognitive function. Lipids 1998, 33:973-980.
160. Willatts P., Forsyth J.S., Dimodugno M.K., Varma S., Colvin M. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 1998, 352:688-691.
161. Yuhas R., Pramuk K., Lien E.L. Human milk fatty acid composition from nine countries varies most in DHA. Lipids 2006, 41:851-858.